ID: ALA3356179

Max Phase: Preclinical

Molecular Formula: C22H25Cl2N3O3

Molecular Weight: 450.37

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)CC(NC(=O)CCCCc1ccc2c(n1)NCCC2)c1cc(Cl)cc(Cl)c1

Standard InChI:  InChI=1S/C22H25Cl2N3O3/c23-16-10-15(11-17(24)12-16)19(13-21(29)30)27-20(28)6-2-1-5-18-8-7-14-4-3-9-25-22(14)26-18/h7-8,10-12,19H,1-6,9,13H2,(H,25,26)(H,27,28)(H,29,30)

Standard InChI Key:  NZSZQHHTXGSVGH-UHFFFAOYSA-N

Associated Targets(Human)

Integrin alpha-V/beta-3 2708 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-6 509 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-5 589 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Integrin alpha-V/beta-8 181 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 450.37Molecular Weight (Monoisotopic): 449.1273AlogP: 4.79#Rotatable Bonds: 9
Polar Surface Area: 91.32Molecular Species: ACIDHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 4.04CX Basic pKa: 7.52CX LogP: 2.10CX LogD: 1.88
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.48Np Likeness Score: -0.41

References

1. Adams J, Anderson EC, Blackham EE, Chiu YW, Clarke T, Eccles N, Gill LA, Haye JJ, Haywood HT, Hoenig CR, Kausas M, Le J, Russell HL, Smedley C, Tipping WJ, Tongue T, Wood CC, Yeung J, Rowedder JE, Fray MJ, McInally T, Macdonald SJ..  (2014)  Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.,  (11): [PMID:25408832] [10.1021/ml5002079]
2. Adams J, Anderson EC, Blackham EE, Chiu YW, Clarke T, Eccles N, Gill LA, Haye JJ, Haywood HT, Hoenig CR, Kausas M, Le J, Russell HL, Smedley C, Tipping WJ, Tongue T, Wood CC, Yeung J, Rowedder JE, Fray MJ, McInally T, Macdonald SJ..  (2014)  Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.,  (11): [PMID:25408832] [10.1021/ml5002079]
3. Adams J, Anderson EC, Blackham EE, Chiu YW, Clarke T, Eccles N, Gill LA, Haye JJ, Haywood HT, Hoenig CR, Kausas M, Le J, Russell HL, Smedley C, Tipping WJ, Tongue T, Wood CC, Yeung J, Rowedder JE, Fray MJ, McInally T, Macdonald SJ..  (2014)  Structure Activity Relationships of αv Integrin Antagonists for Pulmonary Fibrosis by Variation in Aryl Substituents.,  (11): [PMID:25408832] [10.1021/ml5002079]

Source